Beta Bionics

Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation based in Irvine, California. The company employs 254 people and generated $21.1 million in revenue. Beta Bionics specializes in the design, development, and commercialization of medical technology solutions for diabetes management. The company's flagship product is the iLet Bionic Pancreas, a revolutionary insulin delivery system that simplifies diabetes management. Unlike traditional insulin pumps, the iLet does not require carb counting, bolusing, correction factors, or pre-set basal rates. Users only need to input their weight, and the iLet automatically adjusts insulin delivery based on real-time glucose monitoring. Beta Bionics is committed to improving the health outcomes and quality of life for individuals living with diabetes and other glycemic dysregulation conditions. The company's mission is driven by a dedication to innovation and a commitment to making diabetes management simpler, safer, and more effective. For more information about Beta Bionics and the iLet Bionic Pancreas, visit betabionics.com.